San Jose, CA, United States of America

Mandy Loo

USPTO Granted Patents = 12 

 

Average Co-Inventor Count = 6.0

ph-index = 2

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 2014-2023

Loading Chart...
Loading Chart...
12 patents (USPTO):

Title: The Innovative Contributions of Mandy Loo

Introduction

Mandy Loo is a prominent inventor based in San Jose, California, known for her significant contributions to the field of pharmaceuticals. With a total of 12 patents to her name, she has made remarkable strides in developing innovative solutions for various medical conditions.

Latest Patents

Among her latest patents is a groundbreaking invention titled "Substituted pyrimidines and methods of use." This patent provides inhibitors of activin receptor-like kinase 5 (ALK5) and outlines methods to modulate the activity of ALK5, which is crucial for treating disorders mediated by this receptor. Another notable patent is for "Prodrugs of a JAK inhibitor compound for treatment of gastrointestinal inflammatory disease." This invention focuses on compounds that serve as prodrugs of a JAK inhibitor agent, allowing for targeted delivery to the gastrointestinal tract, thereby enhancing treatment efficacy for inflammatory diseases.

Career Highlights

Mandy Loo currently works at Theravance Biopharma R&D IP, LLC, where she continues to push the boundaries of pharmaceutical research. Her work has not only contributed to her personal success but has also advanced the field of drug development significantly.

Collaborations

Throughout her career, Mandy has collaborated with esteemed colleagues, including Daniel D. Long and Robert Murray McKinnell, further enriching her research and innovation efforts.

Conclusion

Mandy Loo's innovative work and dedication to pharmaceutical research exemplify the impact of inventors in advancing medical science. Her contributions continue to pave the way for new treatments and improved patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…